Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235)-Reference-Cited by-同舟云学术

Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235)

Published:2001-07 Issue:1 Volume:58 Page:53-58
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Kucuk Omer,Fisher Emily,Moinpour Carol M,Coleman Dorothy,Hussain Maha H.A,Sartor A.Oliver,Chatta Gurkamal S,Lowe Bruce A,Eisenberger Mario A,Crawford E.David

Publisher

Elsevier BV

Subject

Urology

Reference21 articles.

1. Combined androgen blockade for the treatment of metastatic prostate cancer;Schellhammer;Urology,1997

2. Hormone-refractory (“D3”) prostate cancer;Scher;Urology,1995

3. Second-line hormonal therapy for advanced prostate cancer;Small;J Clin Oncol,1997

4. Bicalutamide (“Casodex”) development;Kolvenbag;Cancer J Sci Am,1997

5. Bicalutamide (Casodex®) in the treatment of prostate cancer;Kolvenbag;Prostate,1998

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bicalutamide Enhances Conventional Chemotherapy in In Vitro and In Vivo Assays Using Human and Canine Inflammatory Mammary Cancer Cell Lines;International Journal of Molecular Sciences;2024-07-19

2. Comparative efficacy of second-generation androgen receptor inhibitors for treating prostate cancer: A systematic review and network meta-analysis;Frontiers in Endocrinology;2023-03-09

3. Repurposing antifungal drugs for cancer therapy;Journal of Advanced Research;2022-09

4. Real‐world use of first‐generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration‐resistant prostate cancer;BJU International;2021-10

5. Design, Synthesis and Cytotoxicity Evaluation of Novel Indole Derivatives Containing Benzoic Acid Group as Potential AKR1C3 Inhibitors;Chemistry & Biodiversity;2020-11-24